• Race to launch weight-loss pills heats up as smaller players advance Reuters Tue, 07 Jul 2026 07:00:00 GMT
• Structure Therapeutics (GPCR) Is Up 7.5% After Strong Oral GLP-1 Phase 2b Data And Insider Sale - Has The Bull Case Changed? Sahm Mon, 06 Jul 2026 19:46:32 GMT
• Structure Therapeutics (GPCR) Is Up 7.5% After Strong Oral GLP-1 Phase 2b Data And Insider Sale - Has The Bull Case Changed? simplywall.st Sun, 05 Jul 2026 19:57:24 GMT
• if you invested $1,000 in structure therapeutics inc adr (gpcr) Stock Titan Sat, 04 Jul 2026 07:50:20 GMT
• Structure Therapeutics (GPCR) Is A Hidden Biotech Multibagger Stock To Buy Now Yahoo Finance Fri, 03 Jul 2026 13:41:31 GMT
• gpcr stock news today | earnings, events & price alerts Intellectia AI Fri, 03 Jul 2026 01:34:32 GMT
• GPCR Stock News Today | Earnings, Events & Price Alerts Intellectia AI Thu, 02 Jul 2026 16:25:22 GMT
• Medicare Obesity Drug Coverage Puts These 3 Biotech Stocks In Focus simplywall.st Tue, 30 Jun 2026 07:00:00 GMT
• Form 4 Structure Therapeutics Inc ADR For: 29 June By Investing.com Investing.com Nigeria Tue, 30 Jun 2026 02:06:20 GMT
• [Form 4] Structure Therapeutics Inc. Insider Trading Activity Stock Titan Tue, 30 Jun 2026 00:47:43 GMT
• Structure Therapeutics, Inc. Sponsored ADR Actuals & Estimates (NASDAQ:GPCR) TradingView Fri, 26 Jun 2026 09:20:22 GMT
• Form 144 Structure Therapeutics Inc. For: 25 June By Investing.com Investing.com Nigeria Thu, 25 Jun 2026 23:34:36 GMT
• After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching 24/7 Wall St. Wed, 24 Jun 2026 07:00:00 GMT
• shareholders approve directors, auditors at 2026 meeting The Globe and Mail Fri, 19 Jun 2026 21:14:00 GMT
• [form 4] structure therapeutics inc. insider trading activity Stock Titan Thu, 18 Jun 2026 21:01:02 GMT
• Director at Structure Therapeutics (NASDAQ: GPCR) gets 39,453 options Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Structure Therapeutics (GPCR) director receives 39,453 share options at $15 Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• structure therapeutics (nasdaq: gpcr) reports 2026 shareholder voting outcomes Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• structure therapeutics (gpcr) grants 39,453-share option award to director Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• structure therapeutics inc (gpcr) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 22:54:03 GMT
• structure therapeutics inc (gpcr) institutional confidence TradingKey Wed, 17 Jun 2026 22:53:58 GMT
• structure therapeutics inc (gpcr) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 22:53:58 GMT
• structure therapeutics inc (gpcr) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 22:25:19 GMT
• structure therapeutics inc (gpcr) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 22:21:41 GMT
• gpcr: board elections, auditor ratification, and clinical milestones marked a pivotal year TradingView Wed, 17 Jun 2026 16:58:32 GMT
• gpcr: all proposals passed; major clinical and financial milestones set for chronic disease portfolio TradingView Wed, 17 Jun 2026 16:46:16 GMT
• structure therapeutics inc (gpcr) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 13:20:00 GMT
• structure therapeutics inc (gpcr) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 12:59:13 GMT
• H.C. Wainwright Reiterates Buy Rating for Structure Therapeutics (GPCR) Yahoo Finance Wed, 17 Jun 2026 07:00:00 GMT
• novo nordisk gains 7% in a week: how should investors play the stock? TradingView Mon, 15 Jun 2026 14:40:00 GMT
• Why Structure Therapeutics (GPCR) Is Up 13.7% After Phase 2b Obesity Data Hit Nature Medicine And ADA simplywall.st Mon, 15 Jun 2026 07:00:00 GMT
• structure therapeutics inc (gpcr) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• Structure Therapeutics (GPCR) Stock After Phase 2b Obesity Data What Does A 2x P/B Multiple Suggest? simplywall.st Sun, 14 Jun 2026 07:00:00 GMT
• Drugmakers race to find a place in the next wave of obesity drugs CNBC Sat, 13 Jun 2026 07:00:00 GMT
• structure therapeutics price target cut to $70.00/share from $100.00 by hc wainwright & co. Moomoo Fri, 12 Jun 2026 11:52:03 GMT
• gpcr maintained by hc wainwright & co. -- price target lowered t GuruFocus Thu, 11 Jun 2026 12:00:00 GMT
• Structure Therapeutics: My Top Small-Cap Pick For The Obesity Market (Upgrade) (GPCR) Seeking Alpha Thu, 11 Jun 2026 07:00:00 GMT
• structure therapeutics price target cut to $70.00/share from $100.00 by hc wainwright & co. Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• h.c. wainwright cuts structure therapeutics stock price target to $70 Investing.com Thu, 11 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains structure therapeutics(gpcr.us) with buy rating, cuts target price to $70 Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• j.p. morgan maintains structure therapeutics(gpcr.us) with buy rating Moomoo Tue, 09 Jun 2026 11:31:00 GMT
• Structure Therapeutics CEO: 'We’re going to see an evolution' in weight loss market CNBC Tue, 09 Jun 2026 07:00:00 GMT
• ADA: AstraZeneca hands Structure a win with ‘relatively underwhelming’ GLP-1 pill data BioSpace Tue, 09 Jun 2026 07:00:00 GMT
• cantor fitzgerald maintains structure therapeutics(gpcr.us) with buy rating, maintains target price $101 Moomoo Mon, 08 Jun 2026 13:33:00 GMT
• ada 2026: structure therapeutics’ aleniglipron shows improved tolerability, but competition looms Citeline News & Insights Mon, 08 Jun 2026 10:57:31 GMT
• how phase 2b oral glp-1 data and phase 3 plans will impact structure therapeutics (gpcr) investors simplywall.st Mon, 08 Jun 2026 08:16:11 GMT
• Structure's GLP-1 obesity pill could compete with others on the market TechTarget Mon, 08 Jun 2026 07:00:00 GMT
• william blair maintains structure therapeutics(gpcr.us) with buy rating Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• structure therapeutics (gpcr) reports positive phase 2 weight loss data for aleniglipron Yahoo Finance Mon, 08 Jun 2026 03:44:00 GMT
• lifesci capital maintains structure therapeutics(gpcr.us) with buy rating, cuts target price to $104 Moomoo Mon, 08 Jun 2026 02:34:27 GMT
• Structure Therapeutics (GPCR) Reports Positive Phase 2 Weight Loss Data for Aleniglipron Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• Does Phase 2b Oral GLP-1 Data on Aleniglipron Change The Bull Case For Structure Therapeutics (GPCR)? Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• structure therapeutics (gpcr) valuation after positive phase 2b aleniglipron data and upcoming phase 3 program simplywall.st Sun, 07 Jun 2026 06:18:23 GMT
• act capital management, llc's structure therapeutics inc(gpcr) holding history GuruFocus Sat, 06 Jun 2026 19:12:01 GMT
• Aleniglipron’s Phase 2b Data Redraws the Oral GLP-1 Efficacy Map — And Raises Hard Questions for Phase 3 Design The Clinical Trial Vanguard Sat, 06 Jun 2026 07:00:00 GMT
• structure therapeutics reports 16.2% weight loss with aleniglipron scanx.trade Sat, 06 Jun 2026 07:00:00 GMT
• structure therapeutics reports weight loss results for oral glp-1 agonist aleniglipron in phase 2b trial geneonline.com Fri, 05 Jun 2026 20:34:26 GMT
• can eli lilly's 2026 acquisition spree diversify growth beyond glp-1s? TradingView Fri, 05 Jun 2026 13:34:00 GMT
• Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• oral obesity drug helped people lose up to 16% body weight in trial Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• oral small molecule glp-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-... Nature Fri, 05 Jun 2026 07:00:00 GMT
• structure therapeutics - aleniglipron shows up to 16.2% weight loss beyond 36 weeks in phase 2b trial TradingView Fri, 05 Jun 2026 07:00:00 GMT
• structure therapeutics inc. releases positive phase 2b data for aleniglipron at ada’s 86th scientific sessions, highlighting signi... Quiver Quantitative Fri, 05 Jun 2026 07:00:00 GMT
• structure therapeutics (gpcr) shares positive phase 2b trial res GuruFocus Fri, 05 Jun 2026 07:00:00 GMT
• structure’s experimental obesity pill shows no signs of liver injury whbl.com Fri, 05 Jun 2026 07:00:00 GMT
• lilly and novo face off at ada 2026 as others seek to compete in obesity BioSpace Fri, 05 Jun 2026 07:00:00 GMT
• gpcr stock chart | structure therapeutics inc (nasdaq:gpcr) ChartMill Wed, 03 Jun 2026 07:00:00 GMT
• structure therapeutics inc - adr (gpcr) news, articles, events & latest updates Stocktwits Sat, 30 May 2026 19:03:30 GMT
• gpcr financials: revenue breakdown, margins & competitor comparison Intellectia AI Wed, 27 May 2026 15:37:54 GMT
• hear structure therapeutics at jefferies and goldman sachs healthcare talks Stock Titan Tue, 26 May 2026 20:05:00 GMT
• Structure Therapeutics Announces Participation in Upcoming Investor Conferences Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• number of shareholders of structure therapeutics inc. – nasdaq:gpcr TradingView Mon, 25 May 2026 18:05:45 GMT
• stifel maintains structure therapeutics inc. - depositary receipt (gpcr) buy recommendation MSN Mon, 25 May 2026 08:33:25 GMT
• structure therapeutics stock is up 47%, but one fund just fully exited a $2.6 million position AOL.com Sun, 24 May 2026 16:26:01 GMT
• why (gpcr) price action is critical for tactical trading Stock Traders Daily Sun, 24 May 2026 14:12:02 GMT
• This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million The Motley Fool Sun, 24 May 2026 07:00:00 GMT
• structure therapeutics stock is up 47%, but one fund just fully exited a $2.6 million position AOL.com Fri, 22 May 2026 13:56:52 GMT
• assessing structure therapeutics (gpcr) valuation after wider quarterly loss and sharp recent share price pullback Sahm Fri, 22 May 2026 10:11:18 GMT
• gpcr stock chart | structure therapeutics inc (nasdaq:gpcr) ChartMill Fri, 22 May 2026 07:00:00 GMT
• assessing structure therapeutics (gpcr) valuation after wider quarterly loss and sharp recent share price pullback simplywall.st Thu, 21 May 2026 07:00:00 GMT
• monashee reduces stake in structure therapeutics amid competitive landscape Intellectia AI Wed, 20 May 2026 20:31:03 GMT
• Monashee Scales Back Its Bet on Structure Therapeutics The Motley Fool Wed, 20 May 2026 07:00:00 GMT
• structure therapeutics inc. - american depositary shares (nq: gpcr The Chronicle-Journal Sun, 17 May 2026 08:02:14 GMT
• highvista strategies sells 69,092 shares of structure therapeutics in q1 2026 - news and statistics IndexBox Sun, 17 May 2026 07:00:00 GMT
• this obesity drug stock has jumped 60% as phase 3 plans advance. a fund just sold $4.7 million Yahoo Finance Sun, 17 May 2026 07:00:00 GMT
• structure therapeutics stock is up 47%, but one fund just fully exited a $2.6 million position AOL.com Fri, 15 May 2026 02:49:05 GMT
• can novo nordisk sustain its glp-1 edge amid lilly's growing pressure? TradingView Thu, 14 May 2026 07:00:00 GMT
• gpcr stock price, quote & chart | structure therapeutics inc (nasdaq:gpcr) ChartMill Thu, 14 May 2026 07:00:00 GMT
• h.c. wainwright maintains structure therapeutics(gpcr.us) with buy rating, maintains target price $100 Moomoo Wed, 13 May 2026 08:45:10 GMT
• h.c. wainwright maintains structure therapeutics(gpcr.us) with buy rating, maintains target price $100 富途牛牛 Tue, 12 May 2026 17:32:00 GMT
• structure therapeutics, inc. sponsored adr (gpcr) gets a buy from cantor fitzgerald The Globe and Mail Tue, 12 May 2026 07:00:00 GMT
• structure therapeutics stock is up 47%, but one fund just fully exited a $2.6 million position AOL.com Mon, 11 May 2026 12:30:00 GMT
• Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position The Motley Fool Sun, 10 May 2026 07:00:00 GMT
• lifesci capital maintains structure therapeutics(gpcr.us) with buy rating, maintains target price $104 富途牛牛 Sun, 10 May 2026 03:22:49 GMT
• structure therapeutics (nasdaq:gpcr) announces quarterly earnings results, beats expectations by $0.04 eps MarketBeat Sat, 09 May 2026 07:00:00 GMT
• structure therapeutics ada data could reframe oral obesity and diabetes prospects Sahm Fri, 08 May 2026 20:12:38 GMT
• structure therapeutics inc. (gpcr) 2026 q1 10-q highlights: clinical pipeline progress, financial results, and strategic risks Minichart Fri, 08 May 2026 17:35:00 GMT
• structure therapeutics reports 16% weight loss with oral glp-1ra aleniglipron in phase 2, prepares for phase 3 obesity trial and a... Minichart Fri, 08 May 2026 13:17:00 GMT
• ccorf maintains structure therapeutics(gpcr.us) with buy rating, maintains target price $101 Moomoo Fri, 08 May 2026 12:35:00 GMT
• guggenheim maintains structure therapeutics(gpcr.us) with buy rating, maintains target price $140 Moomoo Fri, 08 May 2026 11:31:00 GMT
• lifesci capital maintains structure therapeutics(gpcr.us) with buy rating, cuts target price to $104 Moomoo Fri, 08 May 2026 07:00:00 GMT
• pier capital llc sells 148,752 shares of structure therapeutics inc. sponsored adr $gpcr MarketBeat Fri, 08 May 2026 07:00:00 GMT
• william blair maintains structure therapeutics(gpcr.us) with buy rating 富途牛牛 Fri, 08 May 2026 03:18:21 GMT
• william blair maintains structure therapeutics(gpcr.us) with buy rating Moomoo Thu, 07 May 2026 23:31:00 GMT
• Obesity drug gains momentum as Structure (NASDAQ: GPCR) eyes Phase 3, boosts ATM Stock Titan Thu, 07 May 2026 07:00:00 GMT
• structure therapeutics reports first quarter 2026 financial results and recent highlights Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• gpcr (nasdaq: gpcr) expands atm program to $400m capacity Stock Titan Thu, 07 May 2026 07:00:00 GMT
• gpcr financials: income statement, balance sheet & cash flow | structure therapeutics inc adr Stock Titan Thu, 07 May 2026 07:00:00 GMT
• structure therapeutics (nasdaq: gpcr) funds obesity drug push with $1.46b cash Stock Titan Thu, 07 May 2026 07:00:00 GMT
• brief-structure therapeutics inc. q1 net income usd -75.968 million TradingView Thu, 07 May 2026 07:00:00 GMT
• structure therapeutics inc. sponsored adr $gpcr shares acquired by principal financial group inc. MarketBeat Thu, 07 May 2026 07:00:00 GMT
• structure therapeutics expands atm capacity, advances obesity program TipRanks Thu, 07 May 2026 07:00:00 GMT
• obesity pill developer posts 16.3% weight loss, targets phase 3 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• structure therapeutics : quarterly report for quarter ending march 31, 2026 (form 10-q) marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• structure therapeutics inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• structure therapeutics (gpcr) is down 7.2% after strong phase 2 oral glp‑1 obesity data – has the bull case changed? Sahm Mon, 04 May 2026 13:00:50 GMT
• Why Structure Therapeutics (GPCR) Is Down 7.2% After Strong Oral GLP-1 Phase 2 Data And FDA Plans Yahoo Finance Sun, 03 May 2026 07:00:00 GMT
• structure therapeutics (gpcr) is down 7.2% after strong phase 2 oral glp‑1 obesity data – has the bull case changed? simplywall.st Sun, 03 May 2026 07:00:00 GMT
• canaccord genuity initiates coverage of structure therapeutics inc. - depositary receipt (gpcr) with buy recommendation MSN Sun, 03 May 2026 01:15:04 GMT
• avoiding lag: real-time signals in (gpcr) movement Stock Traders Daily Sat, 02 May 2026 11:56:02 GMT
• Structure Therapeutics ADA Data Could Reframe Oral Obesity And Diabetes Prospects simplywall.st Fri, 01 May 2026 07:00:00 GMT
• structure therapeutics (nasdaq:gpcr) shares gap up - should you buy? MarketBeat Fri, 01 May 2026 07:00:00 GMT
• gpcr forecast, price target & analyst ratings | structure therapeutics inc (nasdaq:gpcr) ChartMill Fri, 01 May 2026 07:00:00 GMT
• these stocks are today’s movers: nvidia, nebius, meta, micron, strategy, structure therapeutics, dollar tree, and more MSN Thu, 30 Apr 2026 12:54:26 GMT
• structure therapeutics (gpcr) expected to announce quarterly earnings on thursday MarketBeat Thu, 30 Apr 2026 11:43:02 GMT
• structure therapeutics reports weight loss success in obesity drug trial HarianBasis.co Wed, 29 Apr 2026 13:37:22 GMT
• structure therapeutics (gpcr) morgan stanley 22nd annual global healthcare conference summary Quartr Wed, 29 Apr 2026 13:28:03 GMT
• structure therapeutics (nasdaq:gpcr) upgraded by canaccord genuity group to strong-buy rating MarketBeat Wed, 29 Apr 2026 12:29:35 GMT
• Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at Yahoo Finance Wed, 29 Apr 2026 07:00:00 GMT
• structure therapeutics inc. sponsored adr (nasdaq:gpcr) receives consensus recommendation of "moderate buy" from brokerages MarketBeat Wed, 29 Apr 2026 07:00:00 GMT
• universal beteiligungs und servicegesellschaft mbh buys 67,338 shares of structure therapeutics inc. sponsored adr $gpcr MarketBeat Wed, 29 Apr 2026 07:00:00 GMT
• structure therapeutics (gpcr) jefferies london healthcare conference 2024 summary Quartr Wed, 29 Apr 2026 05:30:19 GMT
Structure Therapeutics Inc.(NASDAQ:GPCR) 
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 r...
Website: https://structuretx.com
Founded: 2016
IPO Price: $15 (Feb 03, 2023)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends